EphB2 has previously been identified as a new target for TGF-β signaling, influencing migration and invasion of breast cancer cells38 and in a separate study the positioning of proliferating cells within the colonic crypts of intestine partly depends on EphB2/SMAD3 signaling39. Here, TGFB1 is linked to breast carcinoma.